02:14 PM EDT, 08/08/2025 (MT Newswires) -- A group led by Doma Perpetual Capital Management and investor Pedro Escudero has acquired nearly 2.7 million shares, or about 5.7% of Pacira Biosciences ( PCRX ) , according to a regulatory filing on Friday.

The filing said that the purpose of the share purchases is to influence Pacira's decision-making, but there is currently no intention to take full control or initiate a merger, reorganization, or changes to management. However, the reporting parties said in the filing they reserve the right to consider such actions if the stock underperforms.

Shares of Pacira Biosciences ( PCRX ) rose past 3% in recent trading activity.

Price: 24.67, Change: +0.90, Percent Change: +3.79